Return on Equity: The amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested. Calculated as: Income from Continuing Operations / Total Common Equity
Athira Pharma, Inc. (ATHA) had Return on Equity of -216.19% for the most recently reported fiscal year, ending 2024-12-31.
Income Statement Financials | |
-- |
|
$-96.94M |
|
-- |
|
-- |
|
$100.90M |
|
$-100.90M |
|
$3.96M |
|
$-96.94M |
|
$-96.94M |
|
$-96.94M |
|
$-96.94M |
|
$-96.94M |
|
$-96.94M |
|
$-100.90M |
|
$-100.45M |
|
38.48M |
|
38.48M |
|
$-2.52 |
|
$-2.52 |
|
Balance Sheet Financials | |
$54.84M |
|
$2.44M |
|
$3.94M |
|
$58.78M |
|
$13.13M |
|
-- |
|
$0.80M |
|
$13.94M |
|
$44.84M |
|
$44.84M |
|
$44.84M |
|
39.04M |
|
Cash Flow Statement Financials | |
$-97.17M |
|
$54.83M |
|
$0.19M |
|
$91.22M |
|
$49.07M |
|
$-42.15M |
|
$11.05M |
|
-- |
|
-- |
|
Fundamental Metrics & Ratios | |
4.18 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-97.20M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
Return on Equity |
-216.19% |
-216.19% |
|
-164.92% |
|
-216.19% |
|
$1.15 |
|
$-2.53 |
|
$-2.53 |